Zobrazeno 1 - 10 of 482 pro vyhledávání: '"MARC B. GARNICK"'
1
Akademický článek
New Advances and Directions in Testicular Cancer
Autor: Marc B Garnick
Publikováno v: Revista Brasileira de Cancerologia, Vol 33, Iss 4 (2023)
Major advances have taken place in the overall management of patients with ali forms of testicular cancer The current articie reviews the approach to diagnosis, staging, and treatment of patients with both seminomatous and nonseminomatous germ celi c
Externí odkaz: https://doaj.org/article/31b5eafe6036462992639c1c7e9c18e5
Zobrazit plný text záznamu
4
Efficacy and safety of relugolix in men with advanced prostate cancer based on baseline body mass index (BMI): A subgroup analysis from the randomized, phase 3 HERO study versus leuprolide (LEU)
Autor: Fred Saad, Daniel J. George, Michael Cookson, Daniel Saltzstein, Ronald F. Tutrone, Marc B. Garnick, Bruce Brown, Sophia Lu, Mark Fallick, Sarah Hanson, E. David Crawford, Neal D. Shore
Publikováno v: Journal of Clinical Oncology. 40:5073-5073
5073 Background: BMI has been correlated with adverse prostate cancer outcomes, such as risk of biochemical failure, mortality and androgen deprivation therapy complications. Relugolix is a FDA-approved, once-daily oral GnRH receptor antagonist that
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d58f3077ab84a7c48911c7035fba86d2
https://doi.org/10.1200/jco.2022.40.16_suppl.5073
Zobrazit plný text záznamu
6
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Autor: Robert Pilarski, Arthur L. Burnett, Lucia R. Languino, Colette Hyatt, Jacqueline Powers, Robert B. Den, Alberto Briganti, Veda N. Giri, Lorelei A. Mucci, Daniel P. Petrylak, Oliver Sartor, Amie Blanco, Daniel W. Lin, Himisha Beltran, E. David Crawford, Karen E. Knudsen, Mary-Ellen Taplin, Brian T. Helfand, Felix Y. Feng, Costas D. Lallas, E. Michael D. Scott, Wayne H. Pinover, R. Jeffrey Karnes, Scott Weissman, Evan Y. Yu, Timothy R. Rebbeck, Ashley H. Woodson, Matthew J. Schiewer, Todd M. Morgan, William B. Isaacs, Jeffrey N. Weitzel, Alanna Kulchak Rahm, Michael S. Cookson, James A. Eastham, S. Bruce Malkowicz, Neha Vapiwala, Kevin R. Loughlin, Raoul S. Concepcion, Ana Maria Lopez, Jose Moreno, Brock O'Neil, Patrick T. Gomella, Patrick Mille, Charnita Zeigler-Johnson, Howard M. Sandler, Kathleen A. Cooney, William Tester, Sarah M. Nielsen, Thomas J. Polascik, Richard C. Wender, Howard R. Soule, Ronald E. Myers, Scott E. Eggener, Marc B. Garnick, Stacy Loeb, Martin Miner, Anthony J. Costello, Gerald L. Andriole, Amanda E. Toland, David Y.T. Chen, Albert Dobi, Joseph K Izes, Mary B. Daly, Leonard G. Gomella, Mark D. Hurwitz, J. Kellogg Parsons, Matthew L. Freedman, Nathan Handley, Adam P. Dicker, Jianfeng Xu, Michael Russell Mullane, Charles J. Ryan, Edouard J. Trabulsi, Anne Calvaresi, James Ryan Mark, Thenappan Chandrasekar, Colin C. Pritchard, Saud H. AlDubayan, Curtis A. Pettaway, William Kevin Kelly, Lindsey Byrne, Peter R. Carroll, Brittany M. Szymaniak, Alicia K. Morgans, Peter A. Pinto, William L. Dahut, Mark Mann, Ganesh V. Raj, James L. Mohler, Wendy Poage, Heather H. Cheng, Grace L. Lu-Yao
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 24
PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a0090e4e87cd120ef0899e6263c77c
https://escholarship.org/uc/item/3mg229rb
Zobrazit plný text záznamu
7
EDITORIAL COMMENT
Autor: Marc B. Garnick, David J. Einstein
Publikováno v: Urology
OBJECTIVE: To investigate the adoption of abiraterone and enzalutamide by urologists. Abiraterone and enzalutamide are oral therapies approved for the treatment of metastatic castration-resistant prostate cancer, a disease most commonly treated by me
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b484184908cca144e8c15dc2aa928c6
https://pubmed.ncbi.nlm.nih.gov/31136769
Zobrazit plný text záznamu
8
Periodical
TREATING PROSTATE CANCER AT ANY STAGE.
Autor: GARNICK, MARC B. (AUTHOR)
Publikováno v: Scientific American. May2024, Vol. 330 Issue 5, p66-69. 4p. 1 Diagram.
Zobrazit plný text záznamu
9
The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy
Autor: David N. Dahdal, Neal D. Shore, Jehonathan H. Pinthus, Marc B. Garnick, Ferenc G. Rick, Thomas E. Keane, Thomas J.R. Beveridge, Andrew V. Schally, Norman L. Block, Robert H. Eckel, Dennis C Marshall, E. David Crawford
Publikováno v: Urologic Oncology: Seminars and Original Investigations.
Purpose To explore how follicle-stimulating hormone (FSH) may contribute to cardiovascular, metabolic, skeletal, and cognitive events in men treated for prostate cancer, with various forms of androgen deprivation therapy (ADT). Materials and methods
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ab588ddef1ad36488d6543d4da3df2f
Zobrazit plný text záznamu
10
The utility of prostate-specific antigen in the management of advanced prostate cancer
Autor: Gerald L. Andriole, Marc B. Garnick, E. David Crawford, Daniel P. Petrylak, Charles L. Bennett
Publikováno v: BJU International. 112:548-560
To review current prostate-specific antigen (PSA) metrics used in monitoring treatment of advanced prostate cancer, with a specific focus on castration-resistant prostate cancer (CRPC) therapies. Explore what is known about the correlation between PS
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a76449b4eaa9dde01dd59685ecc8e9b
https://doi.org/10.1111/bju.12061
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje